SCS Capital Management LLC Invests $3.60 Million in Danaher Corporation $DHR

SCS Capital Management LLC bought a new position in shares of Danaher Corporation (NYSE:DHR) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 18,888 shares of the conglomerate’s stock, valued at approximately $3,598,000.

A number of other large investors also recently bought and sold shares of the stock. Main Street Group LTD purchased a new stake in Danaher in the 1st quarter worth approximately $25,000. JPL Wealth Management LLC purchased a new position in shares of Danaher during the 3rd quarter valued at approximately $25,000. Elevated Capital Advisors LLC purchased a new position in shares of Danaher during the 4th quarter valued at approximately $26,000. WFA of San Diego LLC acquired a new position in shares of Danaher in the 2nd quarter valued at $26,000. Finally, Hilton Head Capital Partners LLC purchased a new stake in Danaher during the fourth quarter worth $27,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

DHR has been the topic of several analyst reports. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. DZ Bank initiated coverage on shares of Danaher in a research report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price objective for the company. Royal Bank Of Canada increased their target price on shares of Danaher from $200.00 to $215.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 22nd. JPMorgan Chase & Co. dropped their target price on Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Finally, Wells Fargo & Company cut their price target on Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research note on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $228.91.

Danaher Price Performance

Danaher stock opened at $202.51 on Monday. The stock has a market capitalization of $142.37 billion, a P/E ratio of 35.97, a P/E/G ratio of 2.52 and a beta of 0.78. The company’s fifty day moving average price is $193.14 and its 200 day moving average price is $192.91. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.25 and a current ratio of 1.65. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The company had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same period in the prior year, the business posted $0.77 earnings per share. As a group, equities research analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.